...
首页> 外文期刊>Pathobiology: journal of immunopathology, molecular and cellular biology >Altered HLA class i and HLA-G expression is associated with IL-10 expression in patients with cervical cancer
【24h】

Altered HLA class i and HLA-G expression is associated with IL-10 expression in patients with cervical cancer

机译:宫颈癌患者中HLA I类和HLA-G表达改变与IL-10表达相关

获取原文
获取原文并翻译 | 示例
           

摘要

Although high-risk human papillomaviruses (HPVs) are an important risk factor in the etiopathogenesis of cervical cancer, increasing evidence suggests that the ability to avoid immune surveillance seems to be linked to the transforming potential of HPV and a rapid progression to cancer. In other cancer models, IL-10 contributes to impair anti-tumor immune response either by downregulating human leukocyte antigen Class I (HLA-I) expression or by increasing HLA-G expression. To comprehend how these alterations could contribute to evasion of immune surveillance in cervical cancer, we analyzed HLA-I, HLA-G and IL-10 expressions by immunohistochemistry in 63 biopsies from patients with cervical intraepithelial neoplasia III (CIN-III) and cervical cancer. Immunohistochemistry showed absent or weak HLA-I expression in 50/59 cases. In these cases, a high percentage had loss of heterozygosis. IL-10 and HLA-G expression were observed in 46.6 and 27.6% of cases, respectively. Concurrent upregulation of IL-10 was found in 87.5% of HLA-G positive cases (p = 0.000). Similarly, a significant association between IL-10 expression and HLA-I downregulation was found (p = 0.028). Finally, we observed higher HLA-G expression in patients with HLA-I downregulation than in those with normal HLA-I expression (p = 0.004). Our results suggest that, in cervical cancer, the IL-10 expression may induce an immunosuppressive environment by upregulating HLA-G expression and downregulating HLA class I expression.
机译:尽管高危型人乳头瘤病毒(HPV)是宫颈癌病因的重要危险因素,但越来越多的证据表明,避免免疫监视的能力似乎与HPV的转化潜力和癌症的快速发展有关。在其他癌症模型中,IL-10通过下调人白细胞抗原I类(HLA-1)表达或增加HLA-G表达来削弱抗肿瘤免疫应答。为了理解这些改变如何有助于避免子宫颈癌的免疫监视,我们通过免疫组织化学分析了宫颈上皮内瘤样变III(CIN-III)和宫颈癌患者的63份活组织检查中的HLA-1,HLA-G和IL-10表达。免疫组化显示50/59例HLA-1表达缺失或弱。在这些情况下,高百分比的杂合子丢失。 IL-10和HLA-G的表达分别在46.6和27.6%的病例中观察到。在87.5%的HLA-G阳性病例中同时出现IL-10上调(p = 0.000)。类似地,发现IL-10表达与HLA-1下调之间显着相关(p = 0.028)。最后,我们观察到HLA-1下调的患者的HLA-G表达高于正常HLA-1的患者(p = 0.004)。我们的结果表明,在宫颈癌中,IL-10表达可能通过上调HLA-G表达和下调HLA I类表达来诱导免疫抑制环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号